Automatically translated from Basque, translation may contain errors. More information here. Elhuyarren itzultzaile automatikoaren logoa

The Lancet warns of the risk of medicalising menopause

  • On March 8, the medical journal The Lancet published a selection of articles on menopause. In his summary, he recalls that menopause is an inescapable stage in the life of half the world's population, but experiences vary greatly from one to the other: some women have few or no symptoms at menopause and climacteric, others have severe, sometimes persistent symptoms that affect their quality of life.

18 March 2024 - 10:49
Arg. © Diego Cervo/123RF
Zarata mediatikoz beteriko garai nahasiotan, merkatu logiketatik urrun eta irakurleengandik gertu dagoen kazetaritza beharrezkoa dela uste baduzu, ARGIA bultzatzera animatu nahi zaitugu. Geroz eta gehiago gara, jarrai dezagun txikitik eragiten.

This battery of articles aims to inform and empower women to help them make decisions, receive empathetic clinical care and have adequate working conditions, if necessary. It also aims to reduce stigma on older women.

In the editorial they have published along with the articles, they have recalled the interest of some companies in using products and services to fight menopause. As an example, hormone replacement therapy is mentioned, which is neither necessary nor appropriate for all women. In general, these messages run the risk of women underestimating themselves, living negatively and inducing excessive medicalization.

Thus, they affirm that it is necessary to make available to women and doctors the appropriate information to make the appropriate decisions before and during menopause. They also underscore the need to continue betting on gender equality in research, in order to reduce the gender bias existing in medicine and increase inclusiveness.


You are interested in the channel: Industria farmazeutikoa
The pharmaceutical industry won 90 billion euros with 19 vaccines funded with public money COVID-19
Companies received public money for research and Northern countries bought vaccines in advance. Meanwhile, multinationals increased vaccine prices. Currently, in the poorest countries, only 23% have total doses, according to the SOMO study.

Discomfort from unlearning pain
“I often felt a lot of pain in my feet, but it was rare because I didn’t associate with a blow or injury and didn’t identify where I came from.” They are words of Iraia Etxebeste, who for six years began to feel unexplained pain under the foot, and for a long time has... [+]

2023-01-18 | Lide Iraola
BioNTech enpresak Twitterri eskatu zion zentsura zitzala Covid-19aren aurkako txerto unibertsalen aldeko mezuak

Farmazia enpresa alemaniarrak hamar mila milioi euro irabazi ditu Covid-19aren aurkako txertoen patenteei esker. Hainbat ikerketak frogatu dute farmazeutiken lobbyek oztopatu dituztela patenteak askatzeko akordioak. BioNTechek sare sozialetako mezuak zentsuratu nahi izan ditu,... [+]


2022-11-09 | ARGIA
Excessive and inadequate drug consumption of opioids
To combat pain, experts warn that drug use of opioids has increased considerably and their use is frequent and unnecessary. Professionals recommend investing in health resources and multidisciplinary treatments rather than prescribing the pill that can lead to dependence and... [+]

2022-06-21 | Estitxu Eizagirre
85% of women who go to abortion prefer the instrumental method, while the industry "imposes" the pharmacological
The Association of Authorized Clinics for Pregnancy Termination has published an investigation. She asked for her decision and reasons for a maximum of 1,536 women who had sought abortion in the ninth week of pregnancy and who had chosen the two methods. 85.74% chose the... [+]

2022-03-29 | ARGIA
COVID-19 pills reach Hego Euskal Herria
Hego Euskal Herria has reached 722 boxes full of pills, intended for patients at high risk of suffering from COVID-19. Paxlovid de Pfizer is the first antiviral pill recommended by the European Patent for COVID-19 and the Spanish Government has spent EUR 253 million on buying... [+]

Punk&roll to violate the silence of those affected by thalidomide
Preparation of toast and breakfast coffee, hairstyle, tooth brushing and makeup. You may feel like simple tasks to start the day, not all of them have the same importance. Placed on the skin of someone with functional diversity, they gain in complexity, although it does not seem... [+]

Bederatzi pertsona milioidun bihurtu dira COVID-19aren aurkako txertoei esker

Txertoa Herriarentzat Aliantzak egindako azterketaren arabera, txertoen fabrikazioa eta salmenta kontrolatzen dituzten farmazia-enpresek lortutako etekinetatik, gutxienez, bederatzi pertsona milioidun bihurtu dira pandemia hasi zenetik. Zerrendaren buruan Moderna eta... [+]


Pandemiarekin aberasten

Zenbat aldiz ari dira gure agintariak, herritarron diruarekin, gauza beragatik ordaintzen? COVID-19aren aurkako txertoen aferan, gutxienez hirutan.


“Gizonentzako pilula antisorgailurik ez egotea bidegabea da, emakumeen gain utzi da ardura”

1960ko hamarkadan asmatu zuten emakumeentzako pilula antisorgailua, baina gaur egun oraindik zergatik ez dute farmazeutikek gizonentzako pilula antikontzeptiborik bultzatu, zergatik geratu dira bertan behera egindako ikerketak, zergatik gizonek ez dute interesik erakutsi?... [+]


2021-03-02 | ARGIA
Jaurlaritza Janssen enpresa farmazeutikoarekin bildu da

AEBetako Janssen farmazeutikak eskatuta egin dute bilera martxoaren 1ean Eusko Jaurlaritzan eta beraien txertoa Europan baimentzeko prozesua zertan den azaldu diete. Jaurlaritzaren hitzetan, lehen bilera horrek "Osasun Sailak eta Janssenek lankidetzan jardun dezaten"... [+]


2020-12-22 | Juan Mari Arregi
Vaccine, business and inequality
The COVID-19 vaccine race is proving that behind this struggle for life there is also business and inequality, that all people and countries are not equal.

2020-12-17 | Juan Mari Arregi
Txertoa, negozioa eta desberdintasuna

COVID-19ren aurkako txertoaren lasterketa erakusten ari da bizitzaren aldeko borroka horren atzean negozioa eta desberdintasuna ere badagoela, pertsona eta herrialde guztiak ez garela berdinak.


2020-12-02 | ARGIA
Erresuma Batuan datorren astean hasiko dira COVID-19aren aurkako lehen txertoak jartzen

Erresuma Batua da koronabirusaren aurkako txertoa onartu eta erabiltzen hasiko den Mendebaldeko lehen herrialdea. Gobernu britainiarrak aurrea hartu dio AEBetakoari Pfizer farmazeutika estatubatuarraren eta BioNTech enpresa alemaniarraren txertoari argi berdea emanez.


Mike Davis, aditua eta ekintzailea
Pandemiak, superkapitalismoa eta biharko gatazkak

Koronabirus pandemia gaitz da ulertzen. Ehunka mila kasu baieztatuta, milaka hilda, nazioak blokeatuta… planeta krisian dago. Nola gertatu da hau? Zein dira izurri globalari bidea erraztu dioten oinarrizko egitura politiko, ekonomiko eta ingurumenekoak? Nondik sortzen... [+]


Eguneraketa berriak daude